CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Eric Linsley to join panel at the MedTech Investing Conference in Minneapolis, MN
News | 05. 10. 2006
